The American Academy Of Pain Medicine

The physicians' voice in pain medicine
  • Foundation
  • Store
  • Career Center
  • Press
  • Join-Renew
Search: Go
Member Login: Login

Enter the AAPM
Members' Community

  • Member Center
  • Patient Center
  • Library
  • Advocacy
  • Practice Management
  • CME
  • Annual Meeting
  • Safe Prescribing Resources
  • PI-CME Portal

Library

Home > Library > For Pain Researchers > 2013 Poster Abstracts
  • Research in the News
  • For Pain Researchers
    • 2013 Poster Abstracts
    • 2012 Poster Abstracts
    • Research Resources
    • Research Presentations
    • Search Clinical Trials (NIH)
    • Register a Clinical Trial (NIH)
    • Medline - US National Library of Medicine
  • Clinical Guidelines and Resources
  • Pain Facts
  • Archives
  • FDA Updates, Recalls and Warnings
  • Presented at the 2013 AAPM Annual Meeting « Back

    215

    The Use of a Respiratory Volume Monitor in the Assessment of Obstructed Breathing and Postoperative Apnea

    Jenny E. Freeman, MD, jfreeman@respiratorymotion.com1, Edward George2, Jordan B. Brayanov, PhD1, C. Marshall MacNabb, MS1, Eunna Cho1, Diane Ladd, DNP3, Michael J. Lalli, BSE1, Christopher Voscopoulos2, (1) Respiratory Motion, Inc., Waltham, Massachusetts, (2) Brigham & Women’s Hospital, Harvard Medical School, Boston, Massachusetts, (3) Midland Internal Medicine, Midland, Michigan

    View Poster

    Introduction: Respiratory assessment to prevent complications associated with opioid pain management in post-operative patients continues to present significant challenge, particularly in patients with obstructive sleep apnea. A non-invasive, continuous Respiratory Volume Monitor (RVM) was developed to provide quantitative measurements of Minute Ventilation (MV), Tidal Volume (TV) and Respiratory Rate (RR). Methods: Real-time, impedance-based RVM data (ExSpiron, Respiratory Motion, Inc., Waltham, MA) acquired from six thoracic electrodes and spirometry data (SpiroAir-LT, Morgan Scientific, Haverhill, MA) were collected simultaneously during normal and simulated obstructed breathing in eight ambulatory volunteers. RVM performance vs. spirometry was evaluated and obstructed breathing patterns characterized. RVM data were also collected from two orthopedic patients with diagnosed obstructive sleep apnea 1) pre-operatively and 2) in the PACU within 20 minutes following administration of the first post-operative dose of narcotic (PCA hydromorphone). All subjects were studied in IRB approved protocols. Results: In the eight volunteers, RVM derived TV readings were highly correlated with spirometry (r>0.96) and decreased from normal values of 1329ml ±117ml to 197ml± 4.53ml during obstructed breathing (approaching physiologic dead space), p<0.0001, (Fig. 1). In two post-operative patients, RVM measurements of TV and MV decreased following narcotic administration and demonstrated periods of apnea (Fig. 2), although oxygen saturations remained above 96%. Conclusions: RVM data demonstrated decreased measurements of MV and TV due to obstructed breathing in both experimental and clinical settings. RVM has potential utility in defining inadequate ventilation to assist in narcotic pain management and improve patient safety, especially in patients at risk for airway obstruction.

    Funding: This study was funded by Respiratory Motion, Inc.

    Figures:

    Poster 215a

    Poster 215b

  • Home
  • Member Center
  • Patient Center
  • Library
  • Advocacy
  • Practice Management
  • CME
  • Annual Meeting
  • Contact Us
  • Members' Community
  • Privacy Policy
  • Sitemap
Close

Members Only Alert Message

Please login to access AAPM member only information.
Forgot your login information?

Sign Up Today!

Join AAPM today and be part of the primary organization for physicians practicing in the specialty of pain medicine and begin accessing AAPM member benefits. 

Join
Or

Log In

Please log in and you will be redirected to the requested page.

Log In